Genmab — Maj 2021
-
11:39 agree E L, for me epco also looks best-in-class
-
we still to have wait to see if Glofi comes with a subcu version, but if not epco clearly looks like a potential winner
-
God morgen
-
God morgen.
-
Spørgsmål til Q&A er meget velkommen.
-
Udover Q&A mandag har Proinvestor
sammen med Nordnet biotekwebinar med Genmab, Bavarian og Zealand Pharma tirsdag. Tlmelding: https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-bavarian-zealand-pharma-genmab/ -
Er det ikke en meget meget lille short interest pt?
-
Lad os se mandag om GMAB viser vejen for GMAB.CO
-
Genmab
@Genmab
·
15m
Our virtual #ASCO21 booth is now live. Visit to learn about our innovative pipeline, next-generation antibody platforms and data presentations at the 2021 @ASCO
Annual Meeting: http://genmab-at-clinicaloncology-2021.com -
Hemophelia market is pretty big, but don’t know what it means on share price. Depends I suppose on market share. https://www.grandviewresearch.com/industry-analysis/hemophilia-treatment-industry
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind